β2-spectrin (SPTBN1) as a therapeutic target for diet-induced liver disease and preventing cancer development

Post time 2021-12-16 13:11:15

journal：Science Translational Medicine

Authors：Shuyun Rao; Xiaochun Yang; Kazufumi Ohshiro; Sobia Zaidi; Zhanhuai Wang; Kirti Shetty; Xiyan Xiang; Md. Imtaiyaz Hassan; Taj Mohammad; Patricia S. Latham; Bao-Ngoc Nguyen; Linda Wong; Herbert Yu; Yousef Al-Abed; Bibhuti Mishra; Michele Vacca; Gareth Guenigault; Michael E. D. Allison; Antonio Vidal-Puig; Jihane N. Benhammou; Marcus Alvarez; Paivi Pajukanta; Joseph R. Pisegna; Lopa Mishra

Published date：2021-12-15

DOI：10.1126/scitranslmed.abk2267

Article link：http://dx.doi.org/10.1126/scitranslmed.abk2267

Article Source：American Association for the Advancement of Science (AAAS)。

Remark：

Post time 2021-12-16 13:11:16

: This post has been completed
Completed attachments will be deleted within 24 hours.

Post time 2021-12-18 01:25:49

: This post has been completed
Completed attachments will be deleted within 24 hours.

Post time 2021-12-19 13:13:26

: This post has been completed
Completed attachments will be deleted within 24 hours.

Post time 2021-12-24 04:22:54

: This post has been completed
Completed attachments will be deleted within 24 hours.

[AAAS] β2-spectrin (SPTBN1) as a therapeutic target for diet-induced liver disease and preventing cancer development

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today